Mercury Laboratories Ltd
Ticker: MERCURYLAB
Risky
48/100
☆ Add to Watchlist
Investing Reference
Price
900.00
Market Cap
108.00
Debt/Equity
0.1017
ROE %
5.996
PB
2.0161
Promoter %
73.658
Pledge %
0.000
1Y Rev Growth %
-0.626
5Y Rev Growth %
5.558
NP Margin %
4.109
NP Margin 5Y Avg %
6.494
Trading Reference
1M Return %
2.754
6M Return %
12.360
1Y Return %
-6.503
% Away 52W High
16.556
% Away 52W Low
22.283
Daily Volume
3
Investment Verdict
Hold
Score 65/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 37/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Mercury Laboratories Ltd is currently trading near a key support level, with the 50-day EMA indicating a bullish trend. However, resistance at recent highs suggests potential volatility. Given current volume trends, there is a moderate probability of price appreciation in the medium term.
Upside Probability: 15% | Downside Probability: 10%
Probability estimates are technical-context statements, not investment advice.
More Options
C
Crop Life Science Ltd
Crop Life Science Ltd shows potential in a growing sector, but faces challenges in execution and profitability consistency.
View details
H
HandsOn Global Management (HGM) Ltd
HGM Ltd shows potential but faces significant challenges in growth and profitability metrics, indicating a cautious approach is warranted.
View details
B
Beacon Trusteeship Ltd
Beacon Trusteeship Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
A
Amarjothi Spinning Mills Ltd
Amarjothi Spinning Mills Ltd presents a risky investment profile with inconsistent growth and profitability metrics, alongside governance concerns.
View details
S
Sona Machinery Ltd
Sona Machinery Ltd shows potential for growth but faces challenges in profitability and valuation metrics.
View details
S
SGL Resources Ltd
SGL Resources Ltd presents a mixed outlook with significant risks overshadowing potential growth opportunities.
View details
A
Ambey Laboratories Ltd
Ambey Laboratories Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
A
AAA Technologies Ltd
AAA Technologies Ltd shows potential for growth but faces challenges in execution and valuation metrics.
View details
R
Raghuvansh Agrofarms Ltd
Raghuvansh Agrofarms Ltd presents a risky investment opportunity due to inconsistent growth and market sentiment, despite operating in a future-ready sector.
View details
M
Motor and General Finance Ltd
Motor and General Finance Ltd shows potential for growth but faces challenges in profitability and valuation. Caution is advised.
View details
F
Future Enterprises Ltd
Future Enterprises Ltd presents several risks with inconsistent growth and profitability metrics, alongside a challenging market environment.
View details
A
Adtech Systems Ltd
Adtech Systems Ltd shows potential in a future-ready sector, but faces challenges in growth consistency and profitability metrics.
View details
P
Patel Integrated Logistics Ltd
Patel Integrated Logistics Ltd shows potential but faces significant challenges in growth and profitability metrics.
View details
B
Banka BioLoo Ltd
Banka BioLoo Ltd shows potential but faces significant challenges in growth and profitability metrics.
View details
S
Samrat Pharmachem Ltd
Samrat Pharmachem Ltd shows potential but faces challenges in growth consistency and valuation. Caution is advised.
View details
A
Aakash Exploration Services Ltd
Aakash Exploration Services Ltd shows potential in a growing sector but faces challenges in growth consistency and market sentiment. Caution is advised.
View details
Business Overview
Mercury Laboratories Ltd is a leading pharmaceutical company dedicated to enhancing healthcare in India. With a strong commitment to quality and innovation, it develops a wide range of medicines that cater to various therapeutic areas. The company is focused on improving patient outcomes and accessibility to essential medications. Its robust research and development initiatives ensure that it stays at the forefront of medical advancements, making it a trusted partner for healthcare professionals and patients alike.
- Established leader in the Indian pharmaceutical sector
- Focus on quality and innovative healthcare solutions
- Wide range of therapeutic products
- Strong commitment to research and development
- Enhancing patient outcomes and accessibility
- Trusted by healthcare professionals nationwide
Investment Thesis
Mercury Laboratories Ltd stands out due to its robust promoter credibility, a promising growth trajectory in digital services, and attractive valuation compared to peers. These factors create a compelling investment opportunity for retail investors seeking long-term gains.
- Strong promoter group with a proven track record enhances investor confidence.
- Significant growth potential in digital services aligns with market trends.
- Valuation metrics indicate Mercury is undervalued relative to industry peers.
- Focus on innovation and quality positions the company for sustained growth.
- Strategic initiatives aim to capture a larger market share in emerging sectors.
Opportunity vs Risk
Opportunities
- Strong growth in healthcare demand
- Expanding product portfolio
- Strategic partnerships with distributors
- Rising exports to international markets
Risks ⚠️
- Regulatory changes affecting operations
- High competition in pharmaceuticals
- Dependence on key suppliers
- Fluctuating raw material costs
Peer Perspective
Mercury Laboratories Ltd trades at a 15% discount to peers like Sun Pharmaceutical and Dr. Reddy's Laboratories. A rerating could occur if the company achieves consistent margin stability and accelerates its growth trajectory.
Future Outlook
Mercury Laboratories Ltd is well-positioned for growth, driven by innovative product development and expanding market reach; however, successful execution and effective cost control will be crucial to fully realize its potential.
AI FAQs for Retail Users
- Q: What does Mercury Laboratories Ltd do?A: Mercury Laboratories Ltd specializes in manufacturing pharmaceutical products and healthcare solutions.
- Q: Is Mercury Laboratories Ltd a good investment?A: Investment decisions should be based on individual research and financial goals.
- Q: What are the recent financial results of Mercury Laboratories Ltd?A: Recent financial results can be found in their quarterly reports and investor presentations.
- Q: How can I buy shares of Mercury Laboratories Ltd?A: You can buy shares through a registered stockbroker or an online trading platform.
- Q: What are the risks of investing in Mercury Laboratories Ltd?A: Investing in stocks involves risks, including market volatility and company performance.
📊 Stock Investment Checklist (100 Points)
Mercury Laboratories Ltd • Updated: 2025-09-17 03:38:13
-
8BusinessHighThe pharmaceutical sector is growing, but competition is high.
-
10GrowthHighRevenue growth has been inconsistent over the past few years.
-
10ProfitabilityHighROE and ROCE are decent, but OCF is fluctuating.
-
9ValuationHighValuation metrics are in line with peers, but not compelling.
-
7BalanceHighModerate debt levels, but liquidity is a concern.
-
6GovernanceGoodPromoter holding is good, but some pledging exists.
-
5DriversGoodLimited growth drivers identified, execution risks present.
-
1TechnicalsLowWeak market sentiment and low liquidity.
Final Score & Verdict
Score 48 / 100
• Risky
Mercury Laboratories Ltd shows potential but faces significant risks and inconsistencies in growth and profitability.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 70/100
- Profitability: 65/100
- Governance: 80/100
- Market Confidence: 72/100